Recent Updates
Recently added Catalysts

Biotech Drugs Starting With U

Every drug page whose name starts with this letter, grouped by the company developing it.
Updated 2026-09-21

72 of the 11,685 drugs in development that BiopharmaWatch tracks have a name starting with U. They are grouped by the company developing them; each link opens the drug's page with its phase, indication, clinical trials, upcoming catalysts and probability of approval. Browse another letter below, or every company on the companies A to Z page.

AbbVie Inc.ABBV

Alkermes plcALKS

Amgen Inc.AMGN

Apollomics Inc.APLM

Bayer AGBAYRY

BioCryst Pharmaceuticals, Inc.BCRX

Boston Scientific CorporationBSX

Bristol-Myers Squibb CompanyBMY

Cellectis S.A.CLLS

Day One Biopharmaceuticals, Inc.DAWN

Eli Lilly and CompanyLLY

Emergent BioSolutions Inc.EBS

GSK plcGSK

Johnson & JohnsonJNJ

Merck & Company, Inc.MRK

Merck KGaAMKGAF

NovaBridge BiosciencesNBP

Novartis AGNVS

Novo Nordisk A/SNVO

Pfizer, Inc.PFE

Praxis Precision Medicines, Inc.PRAX

PTC Therapeutics, Inc.PTCT

Regeneron Pharmaceuticals, Inc.REGN

Repligen CorporationRGEN

Roche Holding AGRHHBY

Roivant Sciences Ltd.ROIV

Sana Biotechnology, Inc.SANA

Takeda Pharmaceutical Company LimitedTAK

Teva Pharmaceutical Industries LimitedTEVA

TG Therapeutics, Inc.TGTX

Ultragenyx Pharmaceutical Inc.RARE

United Therapeutics CorporationUTHR

Unity Biotechnology, Inc.UBX

Upstream Bio, Inc.UPB

UroGen Pharma Ltd.URGN